Nick Kroll ‘produced' John Mulaney's intervention because he ‘was so deeply scared that he was gonna die'
Being the subject of an intervention is never easy, but Nick Kroll is letting it be known that organizing one is no walk in the park either.
During a recent episode of the 'Armchair Expert with Dax Shepard' podcast, Shepard, who is a recovering addict, brought up to Kroll how much he loved John Mulaney's Netflix standup special in which the comedian talks about his 2020 stint in rehab. Shepard wondered if Kroll was at the intervention that led to Mulaney's stay.
'I produced that intervention,' Kroll said.
The 'Big Mouth' creator and star said it was 'so scary and brutal' to go through given that it was the height of the pandemic, he was living in Los Angeles and Mulaney was in New York at the time.
Kroll's wife was also pregnant and he was in the midst of filming the movie 'Don't Worry Darling.'
'John was running around New York City like a true madman,' Kroll recalled. 'And I was so deeply scared that he was gonna die.'
There were complicated feelings and many details to attend to, Kroll said, including who the intervention expert would be and where Mulaney would go for treatment.
'You're all of a sudden going back, being like, 'Oh, oh, oh — that's why I've had an inconsistent friend for the last X amount of time. Oh, this explains that,'' Kroll said. 'And so, it gives you both empathy for them and also a tremendous amount of anger because they've been lying to you.'
Mulaney has since gotten sober and married actress Olivia Munn with whom he shares two young children.
CNN has reached out to representatives for Mulaney for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
This Under-the-Radar Healthcare Stock Could Be a Solid Income Play
CVS Health Corporation (NYSE:CVS) is one of the best dividend stocks for a bear market. Even during economic downturns, people continue to rely on medications, essential consumer products, and affordable local healthcare. CVS Health Corporation (NYSE:CVS) serves as a convenient healthcare and retail destination within communities. A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products. The company's overall business remains solid, thanks to its diversified operations and multiple sources of revenue. In recent years, it has expanded its presence in primary care and launched a subsidiary called Cordavis to focus on developing and marketing biosimilar drugs. Its broad reach across communities and wide range of services are key advantages. Lately, higher Medicare usage and increased post-pandemic healthcare costs have impacted the company's revenue and earnings growth. However, CVS Health Corporation (NYSE:CVS) remains profitable and maintains a solid cash position. In the most recent quarter, it reported $4.6 billion in operating cash flow. Looking ahead to 2025, the company has raised its full-year operating cash flow forecast from around $6.5 billion to approximately $7.0 billion. In addition, CVS Health Corporation (NYSE:CVS) appears to have significant room to grow its dividend. With a cash payout ratio of just 30%, even doubling that figure would still leave it within a sustainable range. Due to this strong cash generation, CVS Health Corporation (NYSE:CVS) has maintained its payouts since 1997. Currently, it offers a quarterly dividend of $0.665 per share and has a dividend yield of 3.96%, as of June 17. While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.
Yahoo
an hour ago
- Yahoo
☕️🥐 FC Breakfast: bizarre Club World Cup moment 🥵, Wirtz's dad 😂
Heat in the USA 🥵 Borussia Dortmund's substitutes watched the match against Mamelodi... from the locker room! With temperatures over 30°, the players preferred to stay cool and watch the game. Liverpool, the family club 🫂 Florian Wirtz is the new star of the Reds. His father is already proudly showing off his nice jersey. Advertisement A family affair. Urawa's supporters 🤯 When Urawa scored against Inter, the supporters were ecstatic in the stands. Even though Inter won 2-1, the stands didn't let up. Yesterday's highlights 🍿 - Club World Cup: Jobe Bellingham scores his first goal with Dortmund 🔥 - 📸 This week's jersey news 👕 - Club World Cup: the huge reason why matches are frequently interrupted TV schedule 📺 6:00 PM: Juventus - Wydad (DAZN) 9:00 PM: Real Madrid - Pachuca (DAZN) 12:00 AM: Salzburg - Al Hilal (DAZN) 3:00 AM: Manchester City - Al Ain (DAZN) This article was translated into English by Artificial Intelligence. You can read the original version in 🇫🇷 here. 📸 FEDERICO PARRA - AFP or licensors
Medscape
an hour ago
- Medscape
Fast Five Quiz: How Much Do You Know About Bell Palsy?
Bell palsy, or idiopathic facial paralysis, is the most common peripheral paralysis of the facial nerve (cranial nerve VII). Many cases of facial nerve paralysis have identifiable etiologies, such as stroke, Lyme disease, or Ramsay Hunt syndrome, but Bell palsy is, by definition, idiopathic in nature. How much do you know about Bell palsy and its management? Check your knowledge with this quick quiz. Type 2 diabetes is associated with several types of peripheral neuropathy, including Bell palsy. The prevalence of peripheral neuropathy among patients with type 2 diabetes has been calculated to be as high as 53.6%. In one retrospective cohort study, 33% of participants with Bell palsy had coexisting type 2 diabetes. Additionally, obesity might increase the risk for Bell palsy. Some studies have concluded that there is a slight female preponderance among patients with Bell palsy, whereas others have found no sex predilection. Even if female sex is not a risk factor, evidence suggests that Bell palsy is associated with pregnancy. The median age of onset is 40 years, and patient age < 15 years is not a risk factor. However, Bell palsy has been identified in children and even infants. Facial nerve trauma can certainly cause symptoms resembling Bell palsy, but Bell palsy is idiopathic and does not have a traumatic etiology. If these symptoms resulted from trauma, the diagnosis would be traumatic facial nerve palsy rather than Bell palsy. Learn more about Bell palsy epidemiology. Lagophthalmos, but not true eyelid ptosis, is a characteristic feature of Bell palsy. Symptoms of Bell palsy typically have a rapid onset, manifesting from 24 to 72 hours and often resolving or partially resolving within a few weeks to 3 months. In Bell palsy, facial paralysis is usually unilateral, and bilateral facial paralysis should lead to consideration and evaluation for other etiologies. Hearing loss is not a typical symptom of Bell palsy. The presence of hearing loss indicates an association with an upper motor neuron lesion or a lesion involving more than the facial nerve. Learn more about Bell palsy presentation. A rapid evidence review on Bell palsy points out that, as the condition is idiopathic, laboratory diagnostics are not required for a diagnosis. Clinical practice guidelines from the American Academy of Otolaryngology-Head and Neck Surgery concur that diagnostic testing is not needed to identify Bell palsy. The guidelines recommend that clinicians should not obtain routine laboratory testing in patients with new-onset Bell palsy, pointing out that this approach is not cost-effective. However, both the rapid evidence review and guidelines state that laboratory testing can help identify systemic causes of facial palsy symptoms, such as Lyme disease or diabetes, when reasonable clinical suspicion exists. Learn more about workup for Bell palsy. Oral corticosteroids are recommended in a rapid evidence review as the first-line treatment for Bell palsy. Guidelines from the American Academy of Otolaryngology-Head and Neck Surgery also recommend this approach in patients age = 16 years with Bell palsy. Antiviral monotherapy has not been demonstrated to influence recovery and should be avoided. However, combination therapy with oral corticosteroids and antivirals should be considered, as this approach consistently results in lower rates of synkinesis and might reduce rates of incomplete recovery. Local injectable anesthetic would not be an appropriate therapy because it would not address the underlying cause, lower motor neuron palsy. There is no evidence-based role for local anesthetic in the treatment of Bell palsy. Electroconvulsive therapy is mostly used in the treatment of severe mood disorders. The mechanism of action would not be expected to be useful in the treatment of facial nerve palsy. Learn more about management of Bell palsy. Along with the Sunnybrook facial grading system, the House-Brackmann scale is widely used to qualify symptom severity of Bell palsy. A patient with obvious facial weakness, inability to move the forehead, incomplete closure of the eyelids, and mouth asymmetry with maximal effort would be grade IV, moderately severe symptoms. Grade I is classified as a normal presentation with full facial function in all areas. Grade II is characterized by slight facial weakness on close inspection, slight synkinesis, and no lagophthalmos. Grade III would exhibit moderate symptoms with noticeable, but not severe, synkinesis; obvious facial asymmetry but not disfiguring; complete eyelid closure with effort; and slightly weak mouth even with maximal effort. Learn more about Bell palsy prognosis.
